SAMANTHA LAMBERTUS: Open Payments
NPI 1730617598 · CLINTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 87 payments from 23 companies in 2025. Trend: 2023 $1,784 · 2024 $1,624 · 2025 $1,675
Food & beverage: $1,675
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $275 |
| AstraZeneca Pharmaceuticals LP | 15 | $243 |
| Novo Nordisk Inc | 9 | $213 |
| Lilly USA, LLC | 6 | $209 |
| GlaxoSmithKline, LLC. | 13 | $137 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Antares Pharma, Inc. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Exact Sciences Corporation | 3 | $47 |
Products named: UBRELVY, VRAYLAR, Ozempic, AIRSUPRA, BREZTRI, REXULTI, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across IN — which companies pay providers there.
